Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dubravka Sertic
Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Increased Cortical Bone Mineralization in Imatinib Treated Patients With Chronic Myelogenous Leukemia
Haematologica
Hematology
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Clinical Cancer Research
Cancer Research
Oncology
The Clinical Relevance of Imatinib Plasma Trough Concentrations in Chronic Myeloid Leukemia. A Belgian Study
Clinical Biochemistry
Medicine
Clinical Biochemistry
Treatment of Chronic Myeloid Leukemia With Generic Imatinib in Patients From Northeastern Part of India
International Journal of Research in Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
Imatinib Mesylate Suppresses Cytokine Synthesis by Activated CD4 T Cells of Patients With Chronic Myelogenous Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
An Analysis of Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations
Mathematical Biosciences
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Simulation
Immunology
Biological Sciences
Medicine
Agricultural
Modeling
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Chronic Myelogenous Leukemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology